{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T14:36:00Z","timestamp":1770561360866,"version":"3.49.0"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":879,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2013,9,15]]},"DOI":"10.1002\/ijc.28145","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T03:53:47Z","timestamp":1362542027000},"page":"1459-1469","source":"Crossref","is-referenced-by-count":21,"title":["The burden and costs of prevention and management of genital disease caused by HPV in women: A population-based registry study in Finland"],"prefix":"10.1002","volume":"133","author":[{"given":"Heini","family":"Salo","sequence":"first","affiliation":[{"name":"Department of Vaccination and Immune Protection\/Vaccination Programme Unit; National Institute for Health and Welfare (THL); FI-00271; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuija","family":"Leino","sequence":"additional","affiliation":[{"name":"Department of Vaccination and Immune Protection\/Vaccination Programme Unit; National Institute for Health and Welfare (THL); FI-00271; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terhi","family":"Kilpi","sequence":"additional","affiliation":[{"name":"Department of Vaccination and Immune Protection\/Vaccination Programme Unit; National Institute for Health and Welfare (THL); FI-00271; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Auranen","sequence":"additional","affiliation":[{"name":"Department of Vaccination and Immune Protection\/Vaccination Programme Unit; National Institute for Health and Welfare (THL); FI-00271; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petri","family":"Tiihonen","sequence":"additional","affiliation":[{"name":"Department of Vaccination and Immune Protection\/Vaccination Programme Unit; National Institute for Health and Welfare (THL); FI-00271; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Lehtinen","sequence":"additional","affiliation":[{"name":"Department of Vaccination and Immune Protection\/Vaccination Programme Unit; National Institute for Health and Welfare (THL); FI-00271; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simopekka","family":"V\u00e4nsk\u00e4","sequence":"additional","affiliation":[{"name":"Department of Vaccination and Immune Protection\/Vaccination Programme Unit; National Institute for Health and Welfare (THL); FI-00271; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miika","family":"Linna","sequence":"additional","affiliation":[{"name":"Department of Vaccination and Immune Protection\/Vaccination Programme Unit; National Institute for Health and Welfare (THL); FI-00271; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka","family":"Nieminen","sequence":"additional","affiliation":[{"name":"Department of Vaccination and Immune Protection\/Vaccination Programme Unit; National Institute for Health and Welfare (THL); FI-00271; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,5]]},"reference":[{"key":"10.1002\/ijc.28145-BIB0001|ijc28145-cit-0001","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/00365540500333566","article-title":"High prevalence of HPV among female students in Finland","volume":"37","author":"Auvinen","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1002\/ijc.28145-BIB0002|ijc28145-cit-0002","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1158\/1055-9965.EPI-04-0754","article-title":"Acquisition and persistence of human papillomavirus infection in younger men: A prospective follow-up study among Danish soldiers","volume":"14","author":"Kjaer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/ijc.28145-BIB0003|ijc28145-cit-0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1002\/ijc.28145-BIB0004|ijc28145-cit-0004","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28145-BIB0005|ijc28145-cit-0005","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28145-BIB0006|ijc28145-cit-0006","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections","volume":"32 Suppl 1","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1002\/ijc.28145-BIB0007|ijc28145-cit-0007","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0b013e31819bd6e0","article-title":"Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors","volume":"113","author":"Smith","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1002\/ijc.28145-BIB0008|ijc28145-cit-0008","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","article-title":"Worldwide burden of cervical cancer in 2008","volume":"22","author":"Arbyn","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1002\/ijc.28145-BIB0009|ijc28145-cit-0009","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex Transm Dis"},{"key":"10.1002\/ijc.28145-BIB0010|ijc28145-cit-0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/381395","article-title":"Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men","volume":"189","author":"Weaver","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1002\/ijc.28145-BIB0011|ijc28145-cit-0011","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.28145-BIB0012|ijc28145-cit-0012","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/ijc.28145-BIB0013|ijc28145-cit-0013","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/oxfordjournals.aje.a112253","article-title":"Effect of a mass screening program on the risk of cervical cancer","volume":"103","author":"Hakama","year":"1976","journal-title":"Am J Epidemiol"},{"key":"10.1002\/ijc.28145-BIB0014|ijc28145-cit-0014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N","article-title":"Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: Recent increase in cervical cancer incidence","volume":"83","author":"Anttila","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28145-BIB0015|ijc28145-cit-0015","unstructured":"Cervical cancer incidence in Finland NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic countries Association of the Nordic Cancer Registries 2012"},{"key":"10.1002\/ijc.28145-BIB0016|ijc28145-cit-0016","volume-title":"Terveydenhuollon yksikk\u00f6kustannukset Suomessa vuonna 2006","year":"2008"},{"key":"10.1002\/ijc.28145-BIB0017|ijc28145-cit-0017","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/0284186X.2011.593547","article-title":"Validation of histological diagnoses in a national cervical screening register","volume":"51","author":"Lonnberg","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1002\/ijc.28145-BIB0018|ijc28145-cit-0018","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/sti.2010.048421","article-title":"Genital warts and cost of care in England","volume":"87","author":"Desai","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1002\/ijc.28145-BIB0019|ijc28145-cit-0019","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.28145-BIB0020|ijc28145-cit-0020","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.28145-BIB0021|ijc28145-cit-0021","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(11)70213-3","article-title":"Efficacy of a bivalent HPV 16\/18 vaccine against anal HPV 16\/18 infection among young women: A nested analysis within the Costa Rica vaccine trial","volume":"12","author":"Kreimer","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1002\/ijc.28145-BIB0022|ijc28145-cit-0022","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males-advisory committee on immunization practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1002\/ijc.28145-BIB0023|ijc28145-cit-0023","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-12-0162","article-title":"Age-specific effectiveness of the Finnish cervical cancer screening programme","author":"Lonnberg","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/ijc.28145-BIB0024|ijc28145-cit-0024","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.28145-BIB0025|ijc28145-cit-0025","first-page":"485","article-title":"The natural history of type-specific human papillomavirus infections in female university students","volume":"12","author":"Richardson","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/ijc.28145-BIB0026|ijc28145-cit-0026","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1055-9965.EPI-10-1108","article-title":"Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women","volume":"20","author":"Winer","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/ijc.28145-BIB0027|ijc28145-cit-0027","doi-asserted-by":"crossref","first-page":"a1343","DOI":"10.1136\/bmj.a1343","article-title":"Pregnancy outcome in women before and after cervical conisation: Population based cohort study","volume":"337","author":"Albrechtsen","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/ijc.28145-BIB0028|ijc28145-cit-0028","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomized, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.28145","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T17:16:51Z","timestamp":1625159811000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.28145"}},"subtitle":["The burden and costs of HPV in Finland"],"short-title":[],"issued":{"date-parts":[[2013,4,5]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9,15]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.28145","relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,5]]}}}